glp-1 .25 mg Weight-Loss Pills: What You Need to Know | News Use of GLP-1 weight-loss drugs
Description
80 However, adverse event reporting systems are inherently limited by underreporting, confounding, and reporting bias, and cannot establish causality
56.7% achieved 20% loss vs 3.1% placebo
If you plan to stay on treatment for years, and the data increasingly suggests you should, then the monthly expense matters as much as the clinical trial data
DOI: 10.1016/j.jtcvs.2017.10.085 [Google Scholar] Honda J, Kimura T, Sakai S, Maruyama H, Tajiri K, Murakoshi N, et al
